ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,014Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 2061

$1.26M Total Retail Price of All Prescriptions

Rank: 61 out of 2061

645 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 645 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 645 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 19,702 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 905 782 1 6
LEVOTHYROXINE SODIUM 899 793 2 3
POTASSIUM CHLORIDE 750 630 3 16
SIMVASTATIN 742 585 4 1
WARFARIN SODIUM 691 658 5 11
OMEPRAZOLE 661 593 6 5
LISINOPRIL 578 480 7 2
AMLODIPINE BESYLATE 541 490 8 4
METOPROLOL TARTRATE 515 448 9 7
METFORMIN HCL 438 335 10 9
CITALOPRAM HBR 428 389 11 20
DONEPEZIL HCL 393 371 12 24
HYDROCODONE-ACETAMINOPHEN 381 314 S3 13 10
CARVEDILOL 377 332 14 22
TRAMADOL HCL 367 320 15 18
SERTRALINE HCL 324 249 16 21
GABAPENTIN 323 213 17 15
OXYCODONE-ACETAMINOPHEN 291 218 S2 18 36
NAMENDA 274 257 19 37
MIRTAZAPINE 241 226 20 46
TRAZODONE HCL 234 115 21 39
CARBIDOPA-LEVODOPA 226 226 22 97
CLOPIDOGREL 201 165 23 29
PREDNISONE 182 151 24 32
NEXIUM 171 134 25 26
NITROFURANTOIN MONO-MACRO 170 159 26 162
RISPERIDONE 170 170 26 66
ALLOPURINOL 163 151 28 28
ATORVASTATIN CALCIUM 162 140 29 8
TAMSULOSIN HCL 158 142 30 30
EXELON 155 155 31 94
HYDROCHLOROTHIAZIDE 154 138 32 12
QUETIAPINE FUMARATE 153 118 33 72
OXYBUTYNIN CHLORIDE 152 152 34 121
OLANZAPINE 143 114 35 132
ZOLPIDEM TARTRATE 141 110 36 23
LANTUS 141 118 36 48
CYMBALTA 139 79 38 59
ISOSORBIDE MONONITRATE ER 136 129 39 42
PLAVIX 135 113 40 49
ALENDRONATE SODIUM 126 106 41 25
BUSPIRONE HCL 125 99 42 115
ATENOLOL 124 121 43 13
OXYCODONE HCL 122 55 S2 44 82
BACLOFEN 122 33 44 123
DIGOXIN 117 117 46 56
POLYETHYLENE GLYCOL 3350 114 105 47 64
VENLAFAXINE HCL 113 77 48 193
METOPROLOL SUCCINATE 108 97 49 19
FLUOXETINE HCL 104 92 50 73
LAMOTRIGINE 100 62 51 186
AMOXICILLIN 98 73 52 121
GLYBURIDE 96 89 R 53 60
FAMOTIDINE 96 92 53 67
PAROXETINE HCL 94 68 55 61
AZITHROMYCIN 93 74 56 34
ESCITALOPRAM OXALATE 93 73 56 77
METOCLOPRAMIDE HCL 93 65 56 138
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 76 59 27
VENLAFAXINE HCL ER 91 71 60 109
CYCLOBENZAPRINE HCL 90 36 R 61 78
CLONIDINE HCL 89 72 62 52
GLIPIZIDE 86 80 63 55
AMIODARONE HCL 85 84 64 168
CIPROFLOXACIN HCL 85 81 64 54
SULFAMETHOXAZOLE-TRIMETHOPRIM 85 72 64 87
PRAMIPEXOLE DIHYDROCHLORIDE 84 33 67 249
OXYCODONE HCL-ACETAMINOPHEN 82 41 S2 68 114
LOSARTAN POTASSIUM 82 76 68 17
PROAIR HFA 82 42 68 40
OXYBUTYNIN CHLORIDE ER 81 72 71 80
AMITRIPTYLINE HCL 81 62 R 71 89
LOVASTATIN 80 77 73 35
SPIRONOLACTONE 77 72 74 62
LOSARTAN-HYDROCHLOROTHIAZIDE 75 57 75 50
LANTUS SOLOSTAR 74 54 76 76
SANTYL 74 71 76 274
ALPRAZOLAM 74 60 76 85
LYRICA 71 26 79 83
ADVAIR DISKUS 70 65 80 57
PROMETHAZINE HCL 70 55 R 80 119
RIVASTIGMINE 69 69 82 358
PROPRANOLOL HCL 68 68 83 143
SINGULAIR 67 53 84 88
MEGESTROL ACETATE 66 37 R 85 198
ALBUTEROL SULFATE 65 65 86 104
GLIMEPIRIDE 64 37 87 33
LIDODERM 62 34 88 106
LEVOFLOXACIN 62 53 88 111
MORPHINE SULFATE ER 61 13 S2 90 166
LIPITOR 61 58 90 70
METHADONE HCL 61 61 S2 90 198
FLUDROCORTISONE ACETATE 60 57 93 350
DIVALPROEX SODIUM ER 60 42 93 188
FINASTERIDE 59 59 95 86
LEVETIRACETAM 59 29 95 102
ROPINIROLE HCL 58 36 97 92
DETROL LA 58 57 97 264
NOVOLOG 57 55 99 102
CRESTOR 57 57 99 31
CLOTRIMAZOLE-BETAMETHASONE 56 52 101 173
MELOXICAM 56 40 101 44
ABILIFY 55 23 103 160
CARISOPRODOL 55 19 R 103 156
SPIRIVA 55 49 103 63
RAMIPRIL 55 43 103 95
DIOVAN HCT 54 52 107 99
PRAVASTATIN SODIUM 54 47 107 14
LANSOPRAZOLE 54 30 107 139
PHENYTOIN 54 0 107 316
TRIAMTERENE-HCTZ 54 41 107 38
PROCRIT 53 53 112 412
SEROQUEL 52 46 113 157
OXYCONTIN 51 48 S2 114 154
NIFEDIPINE ER 51 49 114 134
AMOX TR-POTASSIUM CLAVULANATE 50 46 116 113
NOVOLOG FLEXPEN 50 44 116 177
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.